Neuren Pharmaceuticals Limited

DB:NK9 Stock Report

Market Cap: €950.4m

Neuren Pharmaceuticals Dividend

Dividend criteria checks 0/6

Neuren Pharmaceuticals does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield1.2%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share€0.92
Future Dividend Yield6.1%

Recent dividend updates

No updates

Recent updates

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if NK9's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NK9's dividend payments have been increasing.


Dividend Yield vs Market

Neuren Pharmaceuticals Dividend Yield vs Market
How does NK9 dividend yield compare to the market?
SegmentDividend Yield
Company (NK9)n/a
Market Bottom 25% (DE)1.6%
Market Top 25% (DE)4.8%
Industry Average (Pharmaceuticals)1.2%
Analyst forecast (NK9) (up to 3 years)6.1%

Notable Dividend: Unable to evaluate NK9's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NK9's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate NK9's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as NK9 has not reported any payouts.


Discover strong dividend paying companies